1. Home
  2. CDXS vs BCBP Comparison

CDXS vs BCBP Comparison

Compare CDXS & BCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • BCBP
  • Stock Information
  • Founded
  • CDXS 2002
  • BCBP 2000
  • Country
  • CDXS United States
  • BCBP United States
  • Employees
  • CDXS N/A
  • BCBP N/A
  • Industry
  • CDXS Major Chemicals
  • BCBP Savings Institutions
  • Sector
  • CDXS Industrials
  • BCBP Finance
  • Exchange
  • CDXS Nasdaq
  • BCBP Nasdaq
  • Market Cap
  • CDXS 176.4M
  • BCBP 170.1M
  • IPO Year
  • CDXS 2010
  • BCBP N/A
  • Fundamental
  • Price
  • CDXS $2.47
  • BCBP $8.35
  • Analyst Decision
  • CDXS Buy
  • BCBP Hold
  • Analyst Count
  • CDXS 2
  • BCBP 2
  • Target Price
  • CDXS $11.00
  • BCBP $11.75
  • AVG Volume (30 Days)
  • CDXS 532.0K
  • BCBP 81.5K
  • Earning Date
  • CDXS 05-14-2025
  • BCBP 04-22-2025
  • Dividend Yield
  • CDXS N/A
  • BCBP 7.63%
  • EPS Growth
  • CDXS N/A
  • BCBP N/A
  • EPS
  • CDXS N/A
  • BCBP 0.15
  • Revenue
  • CDXS $59,345,000.00
  • BCBP $63,178,000.00
  • Revenue This Year
  • CDXS $12.62
  • BCBP $25.21
  • Revenue Next Year
  • CDXS $22.11
  • BCBP $10.27
  • P/E Ratio
  • CDXS N/A
  • BCBP $56.04
  • Revenue Growth
  • CDXS N/A
  • BCBP N/A
  • 52 Week Low
  • CDXS $1.90
  • BCBP $8.05
  • 52 Week High
  • CDXS $6.08
  • BCBP $14.04
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 53.65
  • BCBP 37.13
  • Support Level
  • CDXS $2.23
  • BCBP $8.11
  • Resistance Level
  • CDXS $2.59
  • BCBP $8.48
  • Average True Range (ATR)
  • CDXS 0.13
  • BCBP 0.31
  • MACD
  • CDXS 0.05
  • BCBP 0.01
  • Stochastic Oscillator
  • CDXS 81.82
  • BCBP 23.71

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

Share on Social Networks: